This study will last up to 9 weeks. Subjects will visit the clinic up to 14 times. Certain
clinic visits will include a physical examination, lung function tests, inflammatory cell
analysis from nasal secretions and/or sputum, and blood draws. Subjects will inhale an FDA
approved virus through their nose which is known to cause the common cold. All study related
medications and medical examinations will be provided at no cost to the subject. The drugs
used in this study are approved for the age group under study.
Phase:
Phase 4
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Salmeterol Xinafoate Xhance